This medicine is for external use only.Take it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye/ear without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid or ear. Wipe off extra liquid.
Mosight LP Eye Drop is a combination of two medicines: Loteprednol and Moxifloxacin. Loteprednol is a steroid medicine. It blocks the production of certain chemical messengers (prostaglandins) that cause redness, swelling and itching. Moxifloxacin is an antibiotic. It kills bacteria by preventing them from reproducing and repairing themselves. This treats your infection.
Mosight LP Eye Drop may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Mosight LP Eye Drop is probably unsafe to use during lactation.
Limited human data suggest that the drug could represent a significant risk to the baby.
Do not drive unless you are feeling well. Mosight LP Eye Drop may make you feel dizzy or light-headed, you may experience a sudden, transient loss of vision, or you may faint for a short period. This may affect your driving ability.
Mosight LP Eye Drop is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Mosight LP Eye Drop may not be needed in these patients. Please consult your doctor.
Mosight LP Eye Drop is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Mosight LP Eye Drop may not be needed in these patients. Please consult your doctor.
“The following are the results of on-going survey on 1mg.com for Mosight LP Eye Drop. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 12th Apr 2018.